DE MICHELE, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 10.237
NA - Nord America 9.484
EU - Europa 8.779
SA - Sud America 1.480
AF - Africa 292
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 30.298
Nazione #
US - Stati Uniti d'America 9.089
SG - Singapore 5.803
RU - Federazione Russa 4.309
CN - Cina 2.076
BR - Brasile 1.229
IT - Italia 1.189
HK - Hong Kong 1.029
VN - Vietnam 653
DE - Germania 650
FI - Finlandia 554
NL - Olanda 495
UA - Ucraina 430
GB - Regno Unito 254
CA - Canada 246
IE - Irlanda 243
IN - India 202
SE - Svezia 166
AR - Argentina 117
FR - Francia 117
ZA - Sudafrica 114
MX - Messico 107
ES - Italia 80
BD - Bangladesh 75
CI - Costa d'Avorio 69
PL - Polonia 67
JP - Giappone 49
IQ - Iraq 46
TR - Turchia 42
BE - Belgio 39
AT - Austria 38
KR - Corea 35
EC - Ecuador 29
CO - Colombia 27
ID - Indonesia 27
LT - Lituania 23
AE - Emirati Arabi Uniti 21
IR - Iran 21
VE - Venezuela 21
PK - Pakistan 18
NP - Nepal 17
BG - Bulgaria 14
CL - Cile 14
PY - Paraguay 14
UY - Uruguay 14
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
IL - Israele 13
GR - Grecia 12
AZ - Azerbaigian 11
EG - Egitto 11
PH - Filippine 11
AU - Australia 10
KE - Kenya 10
LB - Libano 10
JO - Giordania 9
MA - Marocco 9
PT - Portogallo 9
TN - Tunisia 9
DK - Danimarca 8
PE - Perù 8
RO - Romania 8
SN - Senegal 8
ET - Etiopia 7
KZ - Kazakistan 7
MY - Malesia 7
AL - Albania 6
CR - Costa Rica 6
DZ - Algeria 6
EU - Europa 6
MK - Macedonia 6
SI - Slovenia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
RS - Serbia 5
SA - Arabia Saudita 5
UG - Uganda 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BW - Botswana 4
CH - Svizzera 4
EE - Estonia 4
LU - Lussemburgo 4
LV - Lettonia 4
MD - Moldavia 4
NO - Norvegia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
YE - Yemen 4
AO - Angola 3
DM - Dominica 3
GM - Gambi 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
AM - Armenia 2
BF - Burkina Faso 2
BH - Bahrain 2
Totale 30.218
Città #
Singapore 2.577
Chandler 1.235
Moscow 1.052
Hong Kong 1.028
Ashburn 786
Beijing 653
Millbury 444
Jacksonville 439
Amsterdam 415
Santa Clara 392
Princeton 358
Los Angeles 292
Munich 259
Nanjing 259
Dallas 252
Naples 241
Ho Chi Minh City 236
Hefei 188
Boston 178
Buffalo 167
Wilmington 154
Napoli 152
New York 127
Redondo Beach 121
Helsinki 118
Ottawa 117
Hanoi 116
São Paulo 111
The Dalles 107
Seattle 102
Nanchang 88
Turku 88
Des Moines 87
Houston 83
Woodbridge 82
Chicago 71
Shenyang 65
Denver 58
Dong Ket 58
Mexico City 58
Warsaw 58
Columbus 56
Hebei 56
Jiaxing 56
Norwalk 55
Nuremberg 55
London 51
Johannesburg 49
Brooklyn 48
Chennai 48
Montreal 47
Tianjin 45
Rio de Janeiro 42
Atlanta 39
Orem 38
Tokyo 38
Toronto 38
Rome 36
Changsha 35
Washington 34
Poplar 32
Redwood City 32
Boardman 31
Falls Church 30
Shanghai 30
Frankfurt am Main 29
Phoenix 29
San Mateo 29
Stockholm 29
Lawrence 28
Belo Horizonte 27
Augusta 26
Pune 26
Biên Hòa 25
Kunming 25
Seoul 25
Dublin 24
Kronberg 24
San Jose 24
Ankara 22
Porto Alegre 22
Dhaka 21
Manchester 20
Milan 20
Brasília 19
Da Nang 19
Haiphong 19
Vienna 19
Falkenstein 18
Ninh Bình 18
Nola 18
San Francisco 18
Brussels 17
Guangzhou 17
Guarulhos 17
Mumbai 17
New Delhi 17
Querétaro 17
Goiânia 16
Cape Town 15
Totale 15.249
Nome #
A case of restless leg syndrome in a family with LRRK2 gene mutation. 253
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 184
Alteration of endosomal trafficking is associated with neurodegenerative diseases 169
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 167
Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects. 165
Cognitive decline in Huntington's disease expansion gene carriers 155
Brain structural damage in Friedreich's ataxia. 152
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 150
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 149
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 146
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 144
Modifications of resting state networks in spinocerebellar ataxia type 2 143
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington disease 140
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 135
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 134
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 134
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 132
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome 131
Electrophysiological characterisation in hereditary spastic paraplegia type 5. 130
SPG5 and multiple sclerosis: clinical and genetic overlap? 129
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 129
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 129
CCM3/PDCD10 gene mutation in cerebral cavernous malformations associated with hyperkeratotic cutaneous capillary venous malformations 128
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 127
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 125
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 125
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 124
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 124
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 123
Pathological laughter as onset symptom in atypical parkinsonisms 123
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 123
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 122
Complex phenotype in an Italian family with a novel mutation in SPG3A. 121
Prevalence and features of non-motor symptoms in Wilson's disease 121
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease. 120
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 120
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 120
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 119
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 118
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 118
Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism 118
Be aware of Wolfram syndrome when examining ataxic patients 118
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 117
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 117
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 117
Perseverative Behavior on Verbal Fluency Task in Patients with Huntington's Disease: a Retrospective Study on a Large Patient Sample 117
Electrophysiologic characterization in spinocerebellar ataxia 17 116
DNA damage induced by polyglutamine-expanded proteins. 116
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 116
Suicidal ideation in a European Huntington's disease population. 116
Chorea-acanthocytosis without chorea: Expanding the clinical phenotype 116
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 116
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 116
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 115
Very late onset in ataxia oculomotor apraxia type I. 115
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 115
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 114
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 114
Cutaneous sensory and autonomic denervation in Progressive Supranuclear Palsy 114
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 113
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 113
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 113
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 112
Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients 112
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 112
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 112
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 110
Adult normative values for the PATA Rate Test 110
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. 109
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 109
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 109
Peripheral markers of autophagy in polyglutamine diseases 109
Primary familial brain calcification caused by a novel homozygous MYORG mutation in a consanguineous Italian family. 109
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 109
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. 108
A randomized clinical trial of lithium in multiple system atrophy. 108
Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage. 108
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 107
Animal-Assisted Therapy in Elderly Patients: Evidence and Controversies in Dementia and Psychiatric Disorders and Future Perspectives in Other Neurological Diseases 107
A refined physical and transcriptional map of the SPG9 locus on 10q23.3[#150]q24.2 106
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 106
Assessment of non-motor and autonomic symptoms in Wilson's disease patients 106
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 105
Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay 105
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease 105
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease 104
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. 104
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 104
Reversible valproate-induced subacute encephalopathy associated with a MT-ATP8 variant in the mitochondrial genome 104
Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy. 103
Variable phenotype in a P102L Gerstmann-Sträussler-Scheinker Italian family. 103
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 103
Mutations in the SPAST gene causing hereditary spastic paraplegia arerelated to global topological alterations in brain functional networks 102
Spinocerebellar ataxia type 48: last but not least 102
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 101
Le atassie ereditarie 101
Myocardial (123)I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 101
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 100
A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease. 100
Antiphospholipid-related chorea. 100
Totale 12.068
Categoria #
all - tutte 107.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021780 0 0 0 0 0 160 105 51 124 33 226 81
2021/20222.011 45 19 17 30 26 55 29 87 270 183 367 883
2022/20232.886 437 246 89 251 333 305 20 213 397 425 131 39
2023/20241.774 87 247 241 141 97 159 40 279 10 28 319 126
2024/20259.844 519 540 44 91 285 425 1.043 654 947 977 3.460 859
2025/202610.338 2.083 1.130 1.796 1.705 3.230 394 0 0 0 0 0 0
Totale 30.899